Burlingame, United States
Mednition, founded in 2014 and headquartered in the United States, operates at the intersection of AI, Analytics, Health Care, and Machine Learning. Their innovative product, KATE, promises to empower emergency nurses by enhancing their ability to identify high-risk patients swiftly and with greater accuracy, all while maintaining existing workflows. This capability aligns with their slogan: Empower emergency nurses to save lives.
The company’s latest financial milestone is a $10.00M Series A investment received on 25 September 2019, underlining strong investor confidence. The round was led by Concord Health Partners and Wildcat Capital Management, both of which recognize the transformative potential of Mednition's AI-driven solutions in health care. As Mednition continues to refine its technology and expand its market presence, it stands poised to make a significant impact on emergency care effectiveness, a crucial factor in maintaining investor interest and driving future growth.
